Orthofix Medical Inc. (OFIX)
NASDAQ (NGS) NASDAQ (NGS) Primary 
XFRA Summary
OFIX Chart
People also search for
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction, and an expected European inventory order, partly offset by a steeper-than-anticipated decline among smaller U.S. spine distributors.
Orthofix Medical Q2 Earnings Call Highlights
Orthofix Medical NASDAQ: OFIX reported second-quarter results that management said reflected improving operating trends across several businesses, while continued weakness among smaller U.S. spine distributors remained a headwind. The company reiterated its focus on commercial productivity, disciplined investment and profitable growth rather than pursuing revenue growth at any cost.
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
Orthofix Medical Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 210 | $2,997.32 | $2,209.2 | -$788.12 | -26.29% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 69 | $791.43 | $712.08 | -$79.35 | -10.03% |
| BG Bart Gancher Intech Investment Management LLC | 10,552 | $175,704.92 | $108,474.56 | -$67,230.36 | -38.26% |
 Anthony Scaramucci SkyBridge Capital II LLC | 3.26M | $45.91M | $33.75M | -$12.16M | -26.49% |
 Point72 Asset Management LP Point72 Asset Management LP | 73,021 | $846,248.39 | $755,037.14 | -$91,211.25 | -10.78% |
Orthofix Medical Inc. (OFIX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Orthofix Medical Inc. ever had a stock split?
Orthofix Medical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Massimo Calafiore CEO | NASDAQ (NGS) Exchange | 68752M108 CUSIP |
| US Country | 1,605 Employees | - Last Dividend | - Last Split | 24 Apr 1992 IPO Date |
Overview
Orthofix Medical Inc., a prominent company in the spine and orthopedics sector, operates extensively throughout the United States, as well as in Italy, Germany, the United Kingdom, France, Brazil, and other global regions. The company has structured its operations into two primary divisions: Global Spine and Global Orthopedics, catering to a wide range of spinal and orthopedic healthcare needs. Initially established in 1980, the organization underwent a rebranding from Orthofix International N.V. to Orthofix Medical Inc. in 2018 and is strategically headquartered in Lewisville, Texas. Through a combination of direct sales representatives and distributor channels, Orthofix Medical Inc. services an expansive client base, including hospitals, healthcare facilities, and medical professionals worldwide.
Products and Services
Orthofix Medical Inc.'s product line and services are distinguished between its two operational segments, Global Spine and Global Orthopedics, each tailored to address specific medical conditions and treatment requirements.
- Bone Growth Stimulator Devices:
Under the Global Spine segment, these devices are engineered to enhance bone fusion, offering both adjunctive and noninvasive treatments for cervical and lumbar spine issues. They also provide therapeutic treatments for non-spine related conditions, making them versatile tools in bone health and recovery.
- Motion Preservation and Fixation Implant Products:
These products, also a part of the Global Spine segment, are designed, developed, and marketed for use in surgical spine procedures. They support the spine's natural motion while ensuring stable fixation, catering to a broad range of surgical needs and patient outcomes.
- Biological Products:
The Global Spine segment offers a suite of biological solutions, including fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers and tissues. These products aid physicians in treating various spinal and orthopedic conditions by facilitating natural bone growth and healing.
- Navigation Technologies:
This innovative technology suite features tracked surgical tools, intelligent software, and imaging equipment. Leveraging machine-vision and optical innovations, these technologies enhance the precision and safety of spinal surgeries, falling under the Global Spine segment's umbrella.
- Orthopedic Products for Limb Reconstruction and Deformity Correction:
The Global Orthopedics segment offers a comprehensive range of external and internal fixation products. Paired with enabling digital technologies, these solutions support the entire patient treatment pathway, addressing various orthopedic conditions unrelated to the spine.
